Shiuan Chen

Division of Immunology, Beckman Research Institute of the City of Hope, Duarte, CA 91010

Received 12/18/97 Accepted 7/15/98

9. REFERENCES

1. Green, S.: Steroid receptors and new (anti-) steroidal agents: modulation of oestrogen receptor activity by oestrogens and anti-oestrogens. J. Steroid Biochem. Mol. Biol. 37, 747-751 (1990)

2. Lippman, M. E., Dickson, R. B., Kasid, A., Gelmann, E., Davidson, N., McManaway, M., Huff, K., Bronzert, D., Bates, S., Swain, S., et al.: Autocrine and paracrine growth regulation of human breast cancer. J. Steroid Biochem. 24, 147-154 (1986)

3. Bates, S. E., Davidson, N. E., Valverius, E. M., Freter, C. E., Dickson, R. B., Tam, J. P., Kudlow, J. E., Lippman, M. E., and Salomon, D. S.: Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol. Endocrinol. 2, 543-555 (1988)

4. James, V.H.T., McNeill, J.M., Lai, L.C., Newton, C.J., Ghilchik, M.W., and Reed, M.J.: Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids 50, 269-279 (1987)

5. Miller, W. R., and O'Neill, J.: The importance of local synthesis of estrogen within the breast. Steroids 50, 537-548 (1987)

6. Bulum, S. E., Price, T. M., Mahendroo, M. S., Aitken, J., and Simpson, E. R. : A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J. Clin. Endocrinol. Metab. 77, 1622-1628 (1993)

7. Harada, N.: Aberrant expression of aromatase in breast cancer tissues. J. Steroid Biochem. Mol. Biol. 61, 175-184 (1997)

8. Pasqualini, J. R., Chetrite, G., Blacker, C., Feinstein, M. C., Delalonde, L., Talbi, M., and Maloche, C.: Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J. Clin. Endocrinology and Metablism 81, 1460-1464 (1996)

9. Zhou, C., Zhou, D., Esteban, J., Murai, J., Siiteri, P.K., Wilczynski, S., and Chen, S.: Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction (RT-PCR) J. Steroid Biochem. Mol. Biol. 59, 163-171 (1996)

10. Esteban, J.M., Warsi, Z., Haniu, M., Hall, P.F., Shively, J.E., and Chen, S.: Detection of intratumoral aromatase in breast carcinomas, an immunohistochemical study with clinico-pathologic correlation. J. Amer. Pathol. 140, 337-343 (1992)

11. Sasano, H., Nagura, H., Harada, N., Goukon, Y., and Kimura, M.: Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum. Pathol. 25, 530-535 (1994)

12. Santen, R. J., Martel, J., Hoagland, M., Naftolin, F., Roa, L., Harada, N., Hafer, L., Zaino, R., and Santner, S. J.: Stromal spindle cells contain aromatase in human breast tumors. J. Clin. Endocrinol. Metab. 79, 627-632 (1994)

13. Lu, Q., Nakamura, J., Savinov, A., Yue, W., Weisz, J., Dabbs, D.J., Wolz, G., and Brodie, A.: Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology 137, 3061-3077 (1996)

14. Kitawaki, J., Fukuoka, M., Yamamoto, T., Honjo, H., and Okada, H.: Contribution of aromatase to the deoxyribonucleic acid synthesis of MCF-7 human breast cancer cells and its suppression by aromatase inhibitors. J. Steroid Biochem. Molec. Biol. 42, 267-277 (1992)

15. Zhou, D., Pompon, D., and Chen, S.: Stable expression of human aromatase cDNA in mammalian cells - A useful system for aromatase inhibitor screening. Cancer Res. 50, 6949-6954 (1990)

16. Santner, S.J., Chen, S., Zhou, D., Korsunsky, Z., Martel, J., and Santen, R.J.: Effect of androstenedione on growth of untransfected and aromatase-transfected MCF-7 cells in culture. J. Steroid Biochem. Mol. Biol. 44, 611-616 (1993)

17. Yue, W., Zhou, D., Chen, S., and Brodie, A.: A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene. Cancer Res. 54, 5092-5095 (1994)

18. Macaulay, V.M., Nicholls, J.E., Gledhill, J., Rowlands, M.G., Dowsett, M., and Ashworth, A.: Biological effects of stable overexpression of aromatase in human hormone-dependent breast cancer cells. Br. J. Cancer 69, 77-83 (1994)

19. Lee, K., Macaulay, V.M., Nicholls, J.E., Detre, S., Ashworth, A., and Dowsett, M.: An in vivo model of intratumoural aromatase using aromatase-transfected MCF7 human breast cancer cells. Int. J. Cancer 62, 297-302 (1995)

20. Dowsett, M., Lee, K., Macaulay, M., Detre, S., Rowlands, M., and Grimshaw, R.: The control and biological importance of intratumoural aromatase in breast cancer. J. Steroid Biochem. Mol. Biol. 56, 145-150 (1996)

21. Tekmal, R. R., Ramachandra, N., Gubba, S., Durgam, V. R., Mantione, J., Toda, K., Shizuta, Y., and Dillehay, D. L.: Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities. Cancer Res. 56, 3180-3185 (1996)

22. Sun, X.-Z., Zhou, D., and Chen, S.: Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture studyinvolving aromatase transfected MCF-7 andT-47D cells. J. Steroid Biochem. Mol. Biol., in press (1997)

23. Mahendroo, M.S., Means, G.D., Mendelson, C.R., and Simpson, E.R. : Tissue-specific expression of human P450arom. The promoter responsible for expression in adipose tissues is different from that utilized in placenta. J. Biol. Chem. 266, 11276-1128 (1991)

24. Means, G.D., Kilgore, M.W., Mahendroo, M.S., Mendelson, C.R., and Simpson, E.R. : Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. Molecular Endocrinol. 5, 2005-2013 (1991)

25. Harada, N.: A unique aromatase (P-450arom) mRNA formed by alternative use of tissue-specific exons 1 in human skin fibroblasts. Biochem. Biophys. Res. Commun. 189, 1001-1007 (1993)

26. Mahendroo, M.S., Mendelson, C.R., and Simpson, E.R. : Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J. Biol. Chem. 268, 19463-19470 (1993)

27. Harada, N., Utsumi, T., and Takagi, Y. : Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons I and promoters, and switching of tissue-specific exons I in carcinogenesis. Proc. Natl. Acad. Sci. USA 90, 11312 - 11316 (1993)

28. Toda, K., Simpson, E.R., Mendelson, C.R., Shizuta, Y., and Kilgore, M.W. : Expression of the gene encoding aromatase cytochrome P450 (CYP19) in fetal tissues. Mol. Endocrinol. 8, 210-217 (1994)

29. Wang, J, and Chen, S. : Induction of aromatase gene expression in human placental choriocarcinoma (JAR) cells by phorbol esters. Biochim. Biophys. Acta 1218, 48-54 (1994)

30. Toda, K., Nomoto, S., and Shizuta, Y.: Identification and characterization of transcriptional regulatory elements of the human aromatase cytochrome P450 gene (CYP19) J. Steroid Biochem. Mol. Biol. 56, 151-159 (1996)

31. Michael, M.D., Kilgore, M.W., Morohashi, K.-I., and Simpson, E.R.: Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary. J. Biol. Chem. 270, 13561-13466 (1994)

32. Zhao, Y., Mendelson, C.R., and Simpson, E.R.: Characterization of the sequences of the human CYP19 (aromatase)gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes. Mol. Endocrinol. 9, 340-349 (1995)

33. Zhou, D., Clarke, P., Wang, J., and Chen, S.: Identification of a promoter that controls aromatase expression in human breast cancer and adipose stromal cells. J. Biol. Chem. 271, 15191-15202 (1996)

34. Zhou, D., Zhou, C., and Chen, S.: Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells. J. Steroid Biochem. Mol. Biol. 61, 273-280 (1997)

35. Bulun, S.E., Noble, L.S., Takayama, K., Michael, M.D., Agarwal, V., Fisher, C., Zhao, Y., Hinshelwood, M.M., Ito, Y., and Simpson, E.R.: Endocrine disorders associated with inappropriately high aromatase expression. J. Steroid Biochem. Mol. Biol. 61, 133-139 (1997)

36. Knabbe, C., Lippman, M.E., Wakefield, L.M., Flanders, K.C., Kasid, A., Derynck, R., and Dickson, R.B.: Evidence that transforming growth facter-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48, 417-428 (1987)

37. Zhao, Y., Agarwal, V.R., Mendelson, C.R., and Simpson, E.R.: Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture. J. Steroid Biochem. Mol. Biol. 61, 203-210 (1997)

38. Santner, S.J., Pauley, R.J., Tait, L., Kasseta, J., and Santen, R.J.: Breast cancer stromal cell aromatase expression. J. Clin. Endocr. Metab. 82, 200-208 (1997)

39. Ackerman, G.E., Smith, M.E., Mendelson, C.R., MacDonald, P.C., and Simpson, E.R.: Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J. Clin. Endocrinol. Metab. 53, 412-417 (1981)

40. Santen, R.J., Samojlik, E., and Wells, S.A.: Resistance of the ovary to blockade of aromatization with aminoglutethimide. J. Clin. Endocrinol. Metab. 51, 473-477 (1980)

41. Dexter, R. N., Fishman, L. M., Ney, R. L., and Liddle, G. W.: Inhibition of adrenal corticosteroid synthesis by aminoglytethimide: studies of the mechanism of action. J. Clin. Endocrinol. Metab. 27, 473 (1987)

42. Brodie, A. M.H. and Njar, V.C.O.: Aromatase inhibitors in advanced breast cancer: mechanism of action and clinical implications. Clinical Cancer Res. in press. 43. Zhou, D., Pompon, D., and Chen, S.: Structure-function studies of human aromatase by site-directed mutagenesis: Kinetic properties of mutants Pro308 - Phe, Tyr361 - Phe, Tyr361 - Leu, and Phe406 - Arg. Proc. Natl. Acad. Sci. USA 88, 410-414 (1991)

44. Zhou, D., Korzekwa, K.R., Poulos, T., and Chen, S.: A site-directed mutagenesis study of human placental aromatase. J. Biol. Chem. 267, 762-768 (1992)

45. Kadohama, N., Yarborough, C., Zhou, D., Chen, S., and Osawa, Y.: Kinetic properties of aromatase mutants Pro308Phe, Asp309Asn, and Asp309Ala, and their interactions with aromatase inhibitors. J. Steroid Biochem. Mol. Biol. 43, 693-701 (1992)

46. Chen, S. and Zhou, D.: Functional domains of aromatase cytochrome P450 inferred from comparative analyses of amino acid sequences and substantiated by site-directed mutagenesis experiments. J. Biol. Chem. 267, 22587-22594 (1992)

47. Kadohama, N., Zhou, D., Chen, S., and Osawa, Y.: Catalytic efficiency of expressed aromatase following site-directed mutagenesis. Biochim. Biophys. Acta 1163, 195-200 (1993)

48. Chen, S., Zhou, D., Swiderek, K.M., Kadohama, N., Osawa, Y., and Hall, P. F.: Structure-function studies of human aromatase. J. Steroid Biochem. Mol. Biol. 44, 347-356 (1993)

49. Zhou, D., Cam, L.L., Laughton, C.A., Korzekwa, K.R., and Chen, S.: A mutagenesis study at a postulated hydrophobic region near the active site of aromatase cytochrome P450. J. Biol. Chem. 269, 19501-19508 (1994)

50. Kao, Y.-C., Cam, L. L., Laughton, C. A., Zhou, D., and Chen, S.: Binding characteristics of seven inhibitors of human aromatase. A site-directed mutagenesis study. Cancer Res. 56, 451-460 (1996)

51. Chen, S., Kao, Y.-C., and Laughton, C.A.: Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase. J. Steroid Biochem. Mol. Biol. 61, 107-115 (1997)

52. Kao, Y.-C., Korzekwa, K.R., Laughton, C.A., and Chen, S.: Functional Characterization of Glu-302, Ser-478, and His-480 of Human Aromatase by Site-Directed Mutagenesis. 17th International Congress of Biochemistry and Molecular Biology, August 24-29, 1997, San Francisco, CA Abst. P142 (1997)

53. Laughton, C.A., Zvelebil, M.J.J.M., and Neidle, S.: A detailed molecular model for human aromatase. J. Steroid Biochem. Mol. Biol. 44, 399-407 (1993)

54. Graham-Lorence, S., Amarneh, B., White, R.E., Peterson, J.A., and Simpson, E. R.: A three-dimensional model of aromatase cytochrome P450. Protein Sci. 4, 1065-1080 (1995)

55. Koymans, L. M. H., Moereels, H., and Vanden Bossche, H.: A molecular model for the interaction between vorozole and other non-steroidal inhibitors and human cytochrome P450 10 (P450 aromatase) J. Steroid Biochem. Mol. Biol. 53, 191-197 (1995)

56. Coombes, R.C., Goss, P.E., Dowsett, M., Hutchinson, G., Cunningham, D., Jarman, M., and Brodie, A.M.H.: 4-Hydroxyandrostenedione treatment for postmenopausal patients with advanced breast cancer. Steroids 50, 245-252 (1987)

57. Steele, V., Lubet, R., Eto, I., Kelloff, G., Whitaker, L., and Grubbs, C.: Effect of animal age on the chemopreventive effects of selected agents using a MNU-induced rat mammary cancer model. Proceedings of the 88th Annual Meeting of American Association for Cancer Research, 12-16 April 1997, San Diego, CA; Abst. 2438 (1997)

58. Lubet, R. A., Bowden, C., DeCoster, R., Steele, V. E., Kelloff, G. J., Eto, I., and Grubbs, C. J.: Vorozole: Effects on MNU-induced rat mammary tumors. Proceedings of the 88th Annual Meeting of American Association for Cancer Research, 12-16 April 1997, San Diego, CA; Abst. 2491 (1997)

59. Kumar, R., Sukumar, S., and Barbacid, M.: Activation of ras oncogenes preceding the onset of neoplasia. Science 248, 1101-1104 (1990)

60. Kartin, P. M., Horwitz, K.B., Ryan, D. S., and McGuire, W. L.: Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 103, 1860-1867 (1978)

61. Kagawa, Y.: Impact of the Westemization of the nutrition of the Japanese: changes in physique, cancer, longevity and centenarians. Prev. Med. 7, 205-217 (1978)

62. Verdeal, K. and Ryan D.: Naturally-occurring estrogens in plant foodstuffs: a review. J. Food Prot. 42, 577-583 (1979)

63. London, S. and Willett, W.: Diet and the risk of breast cancer. Hemat. Oncol. Clin. No. Am. 3, 559-576 (1989)

64. Kaldas, R. S. and Hughes, C. L.: Reproductive and general metabolic effects of phytoestrogens in mammals. J. Reprod. Toxic. 3, 81-89 (1989)

65. Howe, G. R., Hirohata, T., Hislop, T. G., Iscovich, J. M., Yuan, J.-M., Katsouyanni, K., Lubin, F., Marubini, E., Modan, B., Rohan, T., Toniolo, P., and Shunzhang, Y.: Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J. Natn. Cancer Inst. 82, 561-569 (1990)

66. Adlercreutz, H., Nousavi, Y., Loukovaara, M., Hamalainen, E.: Lignans, isoflavones, sex hormone metabolism and breast cancer. In: The New Biology of Steroid Hormones (Hochberg RB, Naftolin F. eds) Raven Press, New York, pp. 145-154 (1991)

67. Whitten, P. L. and Naftolin, F.: Dietary estrogens: a biologically active background for estrogen action. In: The New Biology of Steroid Hormones (Hochberg RB, Naftolin F. eds) Raven Press, New York, pp. 155-167 (1991)

68. Block, G., Patterson, B., Subar, A.: Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr. Cancer 18, 1-29 (1992)

69. Markham, K.R.: "Techniques of Flavonoid Identification", Academic Press, London (1982)

70. Medina, J.H., Paladini, A.C., Wolfman, C., Levi de Stein, M., Calvo, D., Diaz, L.E., and Pena, C.: Chrysin (5,7-di-OH- flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties. Biochem. Pharmacol. 40, 2227-2231 (1990)

71. Grayer, R.J.: Flavanoids, in: Methods in plant biochemistry (Dey, P.M., Harborne, J.B., eds.), Vol. 1, Academic Press, London, pp. 283-323 (1989)

72. Cheng, E., Story, C.D., Yoder, L., Hale, W.H., and Burroughs, W.: Estrogenic activity of isoflavone derivatives extracted and prepared from soybean oil meal. Science 118, 164-165 (1953)

73. Franke, A.A., Custer, L.J., Cerna, C.M., and Narala, K.N.: Rapid HPLC analysis of dietary phytoestrogens from legumes and from urine. Proc. Soc. Exp. Biol. Med. 208, 18-26 (1995)

74. Hollman, P.C.H., Hertog, M.G.L., and Katan, M.B.: Role of dietary flavonoids in protection against cancer and coronary heart disease. Biochem. Soc. Transactions 24, 785-789 (1996)

75. Adlercreutz, H., Fotsis, T., Lampe, J., Wahala, K., Makela, T., Brunow, G., and Hase, T.: Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vetetarian women by isotope dilution gas chromatography-mass spectrometry. Scand J. Clin. Lab. Invest. 53 (suppl. 215), 5-18 (1993)

76. Adlercreutz, C.H.T., Goldin, B.R., Gorback, S.L., Hockerstedt, K.A.V., Watanabe, S., Hamalainen, E.K., Markkanen, M.H., Makela, T.H., Wahala, K.T., Hase, T.A., and Fotsis, T.: Soybean phytoestrogen intake and cancer risk. J. Nutr. 125, 757S-770S (1995)

77. Barnes, S.: Effect of genistein on in vitro and in vivo models of cancer. J. Nutr. 125, 777S-783S (1995)

78. Hertog, M.G.L., Hollman, P.C.H., Katan, M.B., and Kromhout, D.: Nutr. Cancer 20, 21-29 (1993)

79. Kao,Y.-C., Zhou, C., Sherman, M., Laughton, C., and Chen, S.: Molecular Basis of the Inhibition of Human Aromatase (Estrogen Synthetase) by Flavone and Isoflavone Phytoestrogens. A Site-directed Mutagenesis Study, Envir Health Perspect, 106, 85-92 (1998)

80. Choi, I., Collante, W.R., Simmen, R.C.M., and Simmen, F.A.: A developmental switch in expression from blastocyst to endometrial/placental-type cytochrome P450 aromatase genes in the pig and horse. Biol. Reproduction 56, 688-696 (1977)

81. Callard,G.V. and Tchoudakova, A.: Evolutionary and functional significance of two CYP19 genes differentially expressed in brain and ovary of goldfish. J. Steroid Biochem. Mol. Biol. 61, 387-392 (1997)

82. Hinishelwood, M.M., Michael, M.D., Sun, T.J., and Simpson, E.R.: Regulation of aromatase expression in the ovary and placenta: a comparison between human and bovine species. J. Steroid Biochem. Mol. Biol. 61, 399-405 (1997)

83. Conley, A., Crobin, J., Smith, T., Hinshelwood, M., Liu, Z., and Simpson, E.R.: Porcine aromatase: studies on tissue-specific, functionally distinct isozymes from a single gene? J. Steroid Biochem. Mol. Biol. 61, 407-413 (1997)

84. Proceedings of the IV International Aromatase Conference. J. Steroid Biochem. Mol. Biol. 61, 107-425 (1997)